Mati	Gill

CEO, aion lABS

Mati is the CEO of the new Israel AI/Pharma Innovation Lab supported by Israel Innovation Authority. He spent over 10 years at Teva Pharmaceutical Industries Ltd. at various senior executive roles including Head of Teva US Public Policy and Corporate Government Affairs, Chief Operations Officer (COO) Global Legal Group and on the Board of Sanara Ventures. 

Prior to Teva Mati was Chief of Staff to Israel's Minister of Public Security. An IDF Maj. (res.) and is a graduate of the IDC MBA Healthcare & Innovation. 

Back to top